Do Guidelines for the Diagnosis and Monitoring of Diabetes Mellitus Fulfill the Criteria of Evidence-Based Guideline Development?
Eva Nagy 1, Joseph Watine 2, Peter S. Bunting 3, Rita Onody 1, Wytze P. Oosterhuis 4, Dunja Rogic 5, Sverre Sandberg 6, Krisztina Boda 7, Andrea R. Horvath 1* 1 Department of Clinical Chemistry, University of Szeged, Medical Faculty, Szeged, Hungary 2 Laboratoire de Biologie Polyvalente, Hôpital Général, Rodez, France 3 Department of Pathology and Laboratory Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada 4 Department of Clinical Chemistry, Atrium Medical Centre, Heerlen, The Netherlands 5 Institute of Clinical Laboratory Diagnosis, Zagreb University School of Medicine, Clinical Hospital Center, Zagreb, Croatia 6 Laboratory of Clinical Biochemistry, Haukeland University Hospital, Bergen, Norway 7 Department of Medical Informatics, University of Szeged, Medical Faculty, Szeged, Hungary * To whom correspondence should be addressed. E-mail: ahorvath{at}clab.szote.u-szeged.hu’ + u + ‘@’ + d + ”//–>. BACKGROUND: Although the methodological quality of therapeutic guidelines (GLs) ha
